NeoGenomics’ (NEO) Buy Rating Reiterated at BTIG Research
BTIG Research reiterated their buy rating on shares of NeoGenomics (NASDAQ:NEO – Free Report) in a report released on Thursday, Marketbeat Ratings reports. They currently have a $28.00 price objective on the medical research company’s stock. A number of other equities research analysts have also recently commented on the stock. Needham & Company LLC increased […]
Live Nation Entertainment’s (LYV) Buy Rating Reiterated at BTIG Research
BTIG Research reissued their buy rating on shares of Live Nation Entertainment (NYSE:LYV – Free Report) in a report released on Monday morning,Benzinga reports. BTIG Research currently has a $215.00 target price on the stock. A number of other research firms have also weighed in on LYV. Susquehanna raised their price objective on shares of […]
TKO Group’s (TKO) “Buy” Rating Reiterated at BTIG Research
TKO Group (NYSE:TKO – Get Free Report)‘s stock had its “buy” rating reaffirmed by BTIG Research in a report issued on Wednesday, Benzinga reports. They presently have a $237.00 price objective on the stock. BTIG Research‘s target price suggests a potential upside of 32.14% from the stock’s previous close. Several other analysts have also issued […]
ArriVent BioPharma’s (AVBP) “Buy” Rating Reiterated at BTIG Research
ArriVent BioPharma (NASDAQ:AVBP – Get Free Report)‘s stock had its “buy” rating restated by research analysts at BTIG Research in a report issued on Friday, Benzinga reports. They presently have a $29.00 price objective on the stock. BTIG Research’s target price indicates a potential upside of 74.07% from the company’s previous close. AVBP has been […]
last updated on 1 Nov 07:49